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Respiratory diseases are leading causes of death and disability; four million people die prematurely 
from chronic respiratory disease globally each year. Chronic Obstructive Pulmonary Disease (COPD) is 
the third leading cause of death worldwide: there are about 65 million people living with COPD and 3 
million deaths annually. About 334 million people suffer from asthma, annual deaths from pneumonia 
are in their millions, over 10 million people develop tuberculosis with over a million people dying from 
it each year, and lung cancer kills 1.6 million people annually [1]. These conditions place huge burdens 
on patients, on those relatives and friends who support them (informal carers), and on health and 
social care providers, services and systems. The symptoms of respiratory diseases are frightening, 
disabling and isolating for patients and carers and their management, through pharmacological and 
non-pharmacological approaches, remains a challenge for all concerned. The requirement for 
supportive and palliative care to identify and address the unmet physical, psychosocial and spiritual 
needs of patients with a range of respiratory conditions, and those who informally support them, is 
increasingly recognised. 
In this edition we present reviews of the current evidence around the mechanisms and management 
of respiratory symptoms with a particular focus on more complex factors and vulnerable populations 
that are more likely to suffer from these conditions but less likely to receive the evidence-based care 
that they could benefit from. 
Physiologic mechanisms of breathlessness are reviewed by Neder et al, exploring the interplay 
between the heart, lungs and muscles and worsening activity-related breathlessness in advanced 
cardio-respiratory disease [2]. Multiple factors including ventilatory insufficiency, hypoxemia and 
neural feedback and metabolic disturbances interact to increase the patient’s ventilatory drive and 
breathlessness. Complementing this, von Leupoldt et al review psychologic mechanisms of 
breathlessness, focusing on recent advances in our understanding of the impact of negative affective 
traits and mental states [3]. Personality as well as depression, fear and anxiety substantially worsen 
the patient’s breathing discomfort but there is sound evidence that positive affect can alleviate 
breathlessness and several management strategies are discussed. Given this, understanding and 
addressing both the physiologic and the psychologic mechanisms of breathlessness is key to managing 
this challenging symptom.   
Moving further into treatment and management, Hui et al [4] and Currow et al [5] provide reviews of 
the pros and cons around one of the controversies in opioid treatment for breathlessness: what is the 
role of using short-acting vs. long-acting opioids for chronic breathlessness? The reviews provide a 
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current state-of-the-art overview, discussing the advantages and disadvantages of each approach, 
highlighting important future research directions.   
Respiratory disease is more prevalent in some sub-populations than others due to increased exposure 
to risk factors, only some of which are self-determined. Peryer et al [6] report on developments in 
supportive and palliative care of people with respiratory problems and pre-existing serious mental 
illness, and in doing so highlight the surprising dearth of relevant research within a population with 
high smoking rates and potential issues around polypharmacy. They identify key priorities to improve 
the delivery of respiratory health care pathways supporting prevention, harm reduction, and 
responsive care that are more inclusive of people living with severe mental illness. Similarly, Gardener 
et al [7] consider recent work in relation to structurally vulnerable populations, focusing on those 
experiencing homelessness or aspects of the criminal justice system. Again, the notable lack of 
research dedicated to supportive and palliative care for this group was remarkable, with the majority 
of papers focused on disease prevalence. They highlight the need for evidence-based interventions to 
reduce the risk of communicable respiratory conditions and a greater understanding of disease 
trajectories and management for these vulnerable populations, including provision of accessible 
appropriate supportive, palliative and end of life care. Identifying and addressing the needs of those 
who support them, both formally and informally, is also noted. Brighton et al [8] report the growing 
literature relating to the care of people with respiratory problems and frailty, which affects at least 
one in five people with chronic respiratory disease. They present recent evidence suggesting the 
potential benefits of rehabilitation, early palliative care and advance care planning for people living 
with respiratory disease and frailty. Their review identifies models of cross-speciality and cross-
professional integration which may have the greatest potential to meet the multidimensional needs 
of this growing, but underserved, group.  
The impact of respiratory disease on informal carers – those family members and friends who, given 
their role, are probably the common background denominator of all of the contributions to this edition 
– is considerable and slowly gaining recognition. We need to think of carers as both clients of care and 
co-workers in care [9]. Patel et al [10] consider both of these roles in their exploration of new evidence 
on the engagement of informal carers, as well as peer support, in pulmonary rehabilitation. The 
evidence base for pulmonary rehabilitation is well-established but referral, uptake and completion 
rates remain poor; the authors outline the potential contributions carers and peer support could make 
to improving uptake and completion, whilst noting that carers themselves could benefit from 
participation. Improving our support and involvement of informal carers has potential gains not only 
for carers themselves, but also for patients, health and social care providers, services and systems. 
We write this editorial in the midst of the Covid-19 pandemic which is changing the landscape of 
formal and informal care to varying degrees internationally. Rapid changes have occurred in the type 
of formal and informal care required, in the volume of that care, and in the way that care is provided; 
some of these changes may continue going forward. Inevitably, therefore, when reading this edition, 
many readers will do so through that new lens. Patients and families living with any of the “big five” 
respiratory conditions of COPD, asthma, acute lower respiratory tract infection, tuberculosis or lung 
cancer [1] are more vulnerable than ever, but this new lens provides a remarkable opportunity to 
review and revise our practice; we have seen during this period how change, and rapid change, is 
possible. The breadth of this edition reports on recent strides to better understand and treat 
breathlessness, and the need to do so inclusively, and can be a stepping-stone for the advances to 
come. 
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